Research Article

Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES)

Volume: 33 Number: 1 February 28, 2023
TR EN

Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES)

Abstract

Introduction: Posterior reversible encephalopathy syndrome (PRES) is a state coupled with a unique clinical and radiological appearance. Various conditions such as preeclampsia/eclampsia, autoimmune diseases, chemotherapy bone marrow and organ transplantation are foreseen and this clinical condition is better illuminated along with imaging, clinical and laboratory features. Therefore, the aim of this study is to describe the clinical and radiological manifestations, diagnosis, and outcome of PRES. Material and methods: A retrospective review of cases of PRES over five years. Patient characteristics, including demographics, comorbidities, specific therapy, and clinical outcome, were analyzed. Diagnosis was made by clinical examination and imaging techniques. Results: Fifteen patients detected PRES between 2015 and 2020 were included. In fifteen patients, the median age was 49.9±17.0 years (25-77 years), 33.3% were men, and 66.7% were women. Two of the patients had active cancer, none had a history of bone marrow or organ transplantation, three had autoimmune disease, four were peripartum, two had chronic renal failure, three had a systemic disease such as hypertension and diabetes, and one had respiratory infection. MR imaging showed vasogenic edema at 100% and restricted diffusions at 33,3%. CT image showed hemorrhage of 30% additionally. Antiedema and convulsion therapy was administered at 100%. Overall, 86,6% of our patients recovered without sequelae in short term. The rate of individuals aged 50 and over was statistically significantly poor in terms of long-term results compared to the group under 50 years of age individuals (p=0.041). Conclusion: In this retrospective analysis of PRES patients, the prognosis was good. CT and MRI contribute to the diagnosis, and various imaging findings can be seen. While the patient's age has an important place in determining the prognosis, other radiological or demographic parameters do not have any effect on short-term or long-term results.

Keywords

computed tomography, magnetic resonance imaging, posterior reversible encephalopathy, syndrome, edema, convulsion, hypertension

References

  1. 1. Gewirtz AN, Gao V, Parauda SC, Robbins MS. Posterior Reversible Encephalopathy Syndrome. Curr Pain Headache Rep. 2021 Feb 25;25(3):19.
  2. 2. Schweitzer AD, Parikh NS, Askin G, et al. Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology. 2017 Apr;59(4):379-386.
  3. 3. Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85:427–432.
  4. 4. Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017 Aug;264(8):1608-1616.
  5. 5. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189:904–912.
  6. 6. Gao B, Lerner A, Law M. The Clinical Outcome of Posterior Reversible Encephalopathy Syndrome. AJNR Am J Neuroradiol. 2016;37:E55–E56.
  7. 7. Bartynski WS, Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. Am J Neuroradiol, 2008; 29(6): 1036–42
  8. 8. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334: 494–500.
  9. 9. Pedraza R, Marik PE, Varon J. Posterior Reversible Encephalopathy Syndrome: A Review. Crit Care & Shock. 2009;12:135–143.
  10. 10. Washio T, Watanabe H, Ogoh S. Dynamic cerebral autoregulation in anterior and posterior cerebral circulation during cold pressor test. J Physiol Sci. 2020 Jan 29;70(1):1.
APA
Akdağ, T., & Güven, B. (2023). Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES). Genel Tıp Dergisi, 33(1), 30-35. https://doi.org/10.54005/geneltip.1158044
AMA
1.Akdağ T, Güven B. Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES). Genel Tıp Derg. 2023;33(1):30-35. doi:10.54005/geneltip.1158044
Chicago
Akdağ, Tuba, and Bülent Güven. 2023. “Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES)”. Genel Tıp Dergisi 33 (1): 30-35. https://doi.org/10.54005/geneltip.1158044.
EndNote
Akdağ T, Güven B (February 1, 2023) Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES). Genel Tıp Dergisi 33 1 30–35.
IEEE
[1]T. Akdağ and B. Güven, “Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES)”, Genel Tıp Derg, vol. 33, no. 1, pp. 30–35, Feb. 2023, doi: 10.54005/geneltip.1158044.
ISNAD
Akdağ, Tuba - Güven, Bülent. “Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES)”. Genel Tıp Dergisi 33/1 (February 1, 2023): 30-35. https://doi.org/10.54005/geneltip.1158044.
JAMA
1.Akdağ T, Güven B. Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES). Genel Tıp Derg. 2023;33:30–35.
MLA
Akdağ, Tuba, and Bülent Güven. “Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES)”. Genel Tıp Dergisi, vol. 33, no. 1, Feb. 2023, pp. 30-35, doi:10.54005/geneltip.1158044.
Vancouver
1.Tuba Akdağ, Bülent Güven. Evaluation of Clinical Manifestations, Radiological Features, and Outcomes of Posterior Reversible Encephalopathy Syndrome (PRES). Genel Tıp Derg. 2023 Feb. 1;33(1):30-5. doi:10.54005/geneltip.1158044